Blog

In the ever-evolving realm of oncology, new research is continuously reshaping our understanding of cancer treatment. A recent systematic review conducted by experts at Moffitt Cancer Center has illuminated the potential role of genomic testing in the management of early-stage prostate cancer. Prostate cancer, being

In a groundbreaking study, scientists at The Hospital for Sick Children (SickKids) have made significant strides towards the development of innovative treatments for medulloblastoma, the leading malignant brain tumor found in children. Medulloblastoma, a highly aggressive form of cancer, poses a formidable challenge to pediatric

A groundbreaking study from the Korea Advanced Institute of Science and Technology (KAIST) sheds light on the intricate gene expression networks crucial for various biological processes, including cancer development and metastasis. This research, led by an esteemed team of professors specializing in biological sciences, has

Mitochondria are recognized as pivotal organelles in maintaining cellular metabolism and signaling. Their role extends beyond merely producing ATP; they are central to regulating reactive oxygen species (ROS) generation and calcium (Ca²⁺) homeostasis. This intricate regulation of mitochondrial Ca²⁺ is essential for numerous cellular functions,

In the realm of oncology, the challenge posed by metastatic tumors continues to loom large. Unlike tumors that remain at their origin, metastatic tumors display an alarming propensity to invade other parts of the body, significantly complicating treatment efforts and negatively impacting patient survival. The

In a groundbreaking development in the fight against cervical cancer, a new therapeutic vaccine known as Vvax001 has shown promising results in inducing regression of high-grade precancerous cervical lesions caused by human papillomavirus type 16 (HPV16). This finding emerges from a phase II clinical trial

A groundbreaking statistical tool has emerged that enhances the ability to predict breast cancer prognosis and treatment response for patients diagnosed with hormone receptor-positive (HR+), HER2-negative breast cancer that has metastasized to the lymph nodes. This tool, known as the RSClin Tool N+, amalgamates clinical

New research has illuminated a potentially groundbreaking approach to treating leptomeningeal brain metastasis (LBM), a dire manifestation of metastatic brain cancer that infests the membranes encasing the brain and spinal cord. This type of metastasis can affect up to 20 percent of individuals battling cancer,

Pere Roca-Cusachs Soulere, an esteemed Professor at the Faculty of Medicine and Health Sciences at the University of Barcelona and the head of the Cellular and Molecular Mechanobiology group at the Institute for Bioengineering of Catalonia (IBEC), has recently achieved a remarkable milestone by being

Recent research published in Clinical Epigenetics has illuminated the molecular landscape of early onset colorectal cancer, a variant of the disease that has been drawing attention due to its increasing incidence among younger populations and underrepresented racial and ethnic minority groups. Colorectal cancer, historically diagnosed